Applications, hearings, determinations, etc.: Medeva Pharmaceuticals CA, Inc.,

Text

---

Federal Register: June 20, 2002 (Volume 67, Number 119)NoticesPage 42059From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr20jn02-112

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 8, 2001, Medeva Pharmaceuticals CA, Inc., which has changed its name to Celltech Manufacturing CA, Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of methylphenidate (1724) a basic class of controlled substances listed in Schedule II.

The firm plans to manufacture the listed controlled substance to make finished dosage forms for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filedno later than August 19, 2002.

Dated: June 10, 2002. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 02-15570Filed6-19-02; 8:45 amBILLING CODE 4410-09-M

---